- Singapore’s first nationwide research initiative dedicated to sarcopenia aims to revolutionise diagnosis and treatment for Asian patients.
- With a unique collection of samples from patients, combined with state-of-the-art investigative platforms, this initiative will bring new insights to the onset and progression of the disease.
- Research outcomes may provide insights to improve quality of life for patients and establish Singapore as a leader in medical innovation and patient care for this largely under recognised and understudied condition.